Alliancebernstein L.P. Acelrx Pharmaceuticals Inc Transaction History

Alliancebernstein L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$1.03 - $1.7 $37,698 - $62,220	-36,600 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$1.01 - $1.81 $34,340 - $61,540	-34,000 Reduced 48.16%	36,600 $52,000
Q2 2020 Aug 13, 2020	BUY	$1.03 - $1.69 $37,183 - $61,009	36,100 Added 104.64%	70,600 $85,000
Q1 2020 May 14, 2020	BUY	$0.76 - $2.07 $9,956 - $27,116	13,100 Added 61.21%	34,500 $41,000
Q2 2019 Aug 14, 2019	BUY	$2.1 - $3.93 $44,940 - $84,102	21,400 New	21,400 $54,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.